Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in own shares executed under the company's share buyback programme.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
- Shares Purchased: 1,600,000 ordinary shares
- Purchase Date: August 15, 2025
- Purpose: Cancellation under the second tranche of the buyback programme announced on July 31, 2025
- Price Range: Highest 359.90 pence; Lowest 354.90 pence
- Volume Weighted Average Price: 357.1774 pence
- Post-Transaction Share Capital: 8,973,306,495 ordinary shares (including 3,880,205 treasury shares)
- Voting Shares: 8,969,426,290
Material Changes
The primary material change is the reduction in the number of outstanding shares due to the cancellation of 1,600,000 shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies beyond the standard disclaimer that the announcement does not constitute an offer for securities. It references the Market Abuse Regulation regarding the availability of individual trade breakdowns.
Investor Verification Checklist
- Verify the total number of shares purchased under the full buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the current buyback tranche.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updated treasury share counts and voting rights calculations.